The PRISM-5 is a dynamic interview that utilizes information obtained throughout the interview to create questions that are specific to each respondent’s lifetime experiences.
Tailored Interview Questions and Answers.Attention Deficit Hyperactivity Disorder.The PRISM-5 assesses the following DSM-5 disorders:.The information collected is designed to assist in the differentiation between primary and substance-induced psychiatric disorders. The information collected can be used to generate current and lifetime substance use and psychiatric disorder diagnoses. The PRISM-5 is ideal for substance screening and the diagnosis of substance use and psychiatric disorders since its questions are detailed and comprehensive. Since that time, computerized versions of the PRISM for DSM-IV disorders (PRISM-CV-IV) and DSM-5 disorders (PRISM-5) have been developed and fully tested. To address the lack of a diagnostic interview that was suitable for co-morbidity research, the PRISM was developed in 1990 as a paper and pencil questionnaire based on DSM-III-R criteria. It is asemi-structured diagnostic interviewdesigned to diagnose DSM-5 substance and psychiatric disorders in individuals who drink alcohol or use drugs heavily. The Psychiatric Research Interview for Substance and Mental Disorders, Computerized Version for DSM-5 Disorders (PRISM-5) was developed by Dr.
Hasin’s diagnostic research interview, the PRISM, is in use in numerous studies of the relationship of substance and psychiatric disorders in the U.S. Hasin has over 450 publications, including papers on time trends and state-level influences on cannabis use, cannabis use disorder, binge drinking and alcohol use disorders and in DSM-5 definitions of substance use disorders in general population and clinical samples. In the past, she has been President of the American Psychopathological Association and has served as a member of many other national advising and consultative groups. Hasin is on the Board of Directors of the College on Problems of Drug Dependence, is a member of the steering committee of the Alcohol Clinical Trials Initiative (ACTIVE), and is the text editor for the substance use disorder sections of DSM-5-TR. Her studies on drugs and alcohol have been continously funded by NIDA and NIAAA since 1990.ĭr. Hasin’s current research focuses on policy and other large-scale social influences on time trends in cannabis use and cannabis-related harms, and on concepts and measures of addiction and recovery/remission across psychoactive substances. Hasin directs the Substance Dependence Research Group in the Department of Translational Epidemiology, and the NIDA-funded Substance Abuse Epidemiology Training Program (SAETP) at Columbia University. in epidemiology from Columbia University in 1986. Her research focuses on drug and alcohol disorders and psychiatric comorbidity. Deborah Hasin is Professor of Clinical Epidemiology at Columbia University in the College of Physicians and Surgeons, Department of Psychiatry, with a joint appointment in the Mailman School of Public Health, Department of Epidemiology.